TIGIT and neoplasm: Furthermore, we established tumor‐bearing mouse models and proved that anti‐TIGIT, anti‐CD96, and anti‐PD1 could remarkably inhibit the growth of CC cells in vivo; yet no statistical differences were found between these three groups (Figure 5F,G).